Advertisement
News
Advertisement

Research and Markets: Pharmaceutical Bundle - Includes Market Anaylsis of Anti-Infective Drugs, Cell Therapy, Medical Nanotechnolgy plus much more

Fri, 10/05/2012 - 9:35am
The Associated Press

DUBLIN--(BUSINESS WIRE)--Oct 5, 2012--Research and Markets ( http://www.researchandmarkets.com/research/75jrgt/pharmaceutical ) has announced the addition of the "Pharmaceutical Bundle" report to their offering.

The Pharmaceutical Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Anti-Infective Drugs Markets - Cell Therapy Markets - Cell-Based Assays for Drug Discovery - Companion Biomarkers in Drug Development - Indian Pharmaceutical Industry - Medical Nanotechnology Markets - Pharmacogenomics for Clinical Use and in Drug Development - Therapeutic Monoclonal Antibodies Markets Anti-Infective Drugs Markets This report analyzes the anti-infective drugs market and highlights the existing and developing anti-infectives used to ameliorate infectious diseases' afflictions on humankind. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Particular attention is paid to the clinical market segment and the pharmaceutical/biotechnology companies involved in anti-infective drugs with specific emphasis on each company's sales focus, product portfolio and R&D pipeline.

Cell Therapy Markets The goal of this report is to review the market for cell therapy products using screening reagents and instruments for analysis of individual components in tissue samples, blood, serum or plasma. It defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including the research labs, hospital labs and commercial laboratories. Additionally, the numbers of institutions using this type of cell therapy and the factors that influence purchases are discussed.

Cell-Based Assays for Drug Discovery The purpose of this examination is to describe the specific segments of the global drug discovery tools market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this study examines the markets for small lab equipment all the way up to highly automated, large automated platforms, as well as accessory equipment such as reagents, supplies and manufacturers' original equipment manufacturer (OEM) additional equipment.

Companion Biomarkers in Drug Development The term companion biomarker means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have long played an important role in diagnostic medicine as evidenced by the intense use of specific clinical laboratory tests in the diagnosis of disease.

Indian Pharmaceutical Industry The purpose of this TriMark Publications study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. This sector includes all of the generally-accepted pharmaceutical manufacturing activities that are currently used today, including the bulk drug industry, formulations and major therapeutic segments. It examines these clinical supplies as utilized in hospitals, clinics and doctor's offices.

Medical Nanotechnology Markets This report covers the specific segments of the medical nanotechnology markets, with particular emphasis on those segments where this emerging technology is or shows the potential to be most impactful. Nanotechnology, a field of science and technology that aims to control matter at the atomic, molecular and macromolecular level, potentially has far-reaching and paradigm-shifting implications for biology, drug discovery and medical technologies. The discipline has already yielded healthcare discoveries that have been used for drug delivery and diagnostic purposes.

Pharmacogenomics for Clinical Use and in Drug Development This publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity.

Therapeutic Monoclonal Antibodies Markets This report reviews the market for medical products based on emerging therapeutic monoclonal antibodies. It defines the dollar volume of sales in the U.S. and worldwide, and it analyzes the factors that influence the size and the growth of the market segments. The study goes on to discuss in detail the trends that have developed which have stimulated this market and surveys many of the companies marketing, manufacturing or developing monoclonal antibodies therapies. Monoclonal antibodies for non-therapeutic purposes--used primarily in life science and research applications--are not discussed in this review. Moreover, antibody process technology is not covered.

Please note that the price quoted includes the 15% reduction For more information visit http://www.researchandmarkets.com/research/75jrgt/pharmaceutical

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector:Pharmaceuticals KEYWORD: INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL SOURCE: Research and Markets Copyright Business Wire 2012 PUB: 10/05/2012 09:35 AM/DISC: 10/05/2012 09:35 AM http://www.businesswire.com/news/home/20121005005439/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading